Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

Seo‐Youn Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2434-8779; OpenAlex author ID A5075837214. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 9

  1. Automated Resectability Classification of Pancreatic Cancer CT Reports with Privacy-Preserving Open-Weight Large Language Models: A Multicenter Study. Co-author DOI 10.1007/s10916-025-02248-2↗
  2. Imaging classification of pancreatic ductal adenocarcinoma with histological large duct pattern. Co-author DOI 10.1007/s00330-024-10810-8↗
  3. Important Radiologic and Clinical Factors for Predicting Overall Survival in Pancreatic Adenocarcinoma Patients Who Underwent FOLFIRINOX. Co-author DOI 10.1097/mpa.0000000000002330↗
  4. Use of individualized 3D-printed models of pancreatic cancer to improve surgeons' anatomic understanding and surgical planning. Co-author DOI 10.1007/s00330-023-09756-0↗
  5. Modified non-flared fully covered self-expandable metal stent for preoperative biliary drainage in pancreatic cancer. Co-author DOI 10.1111/jgh.15733↗
  6. A Comparative Study of Survivor Outcomes between Preoperative Evaluation Using CT Alone and Combined CT and MRI in Patients with Pancreatic Ductal Adenocarcino… Co-author DOI 10.3348/jksr.2020.0078↗
  7. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture ana… Co-author DOI 10.1007/s00330-018-5574-0↗
  8. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal ad… Co-author DOI 10.1016/j.crad.2017.07.009↗
  9. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings. Co-author DOI 10.2214/ajr.15.14974↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jisun Lee · 2 shared papers, 2024–2025 · strength 0.49
  2. Jeong Ah Hwang · 2 shared papers, 2024–2025 · strength 0.49
  3. Ijin Joo · 2 shared papers, 2019–2024 · strength 0.42
  4. Jung Hoon Kim · 2 shared papers, 2019–2024 · strength 0.42
  5. Ji Eun Lee · 2 shared papers, 2021–2024 · strength 0.42
  6. Sunyoung Lee · 2 shared papers, 2021–2024 · strength 0.42
  7. Ji Hye Min · 2 shared papers, 2023–2025 · strength 0.41
  8. Sae‐Jin Park · 1 shared paper, 2024 · strength 0.31
  9. Ju Dong Yang · 1 shared paper, 2025 · strength 0.23
  10. Jeong Hyun Lee · 1 shared paper, 2025 · strength 0.23
  11. Chorog Song · 1 shared paper, 2023 · strength 0.18
  12. Seung-Ju Moon · 1 shared paper, 2023 · strength 0.18
  13. So Jeong Yoon · 1 shared paper, 2023 · strength 0.18
  14. Jin Seok Heo · 1 shared paper, 2023 · strength 0.18
  15. In Woong Han · 1 shared paper, 2023 · strength 0.18
  16. Sang Hyun Shin · 1 shared paper, 2023 · strength 0.18
  17. Bora Lee · 1 shared paper, 2021 · strength 0.16
  18. Sang‐Heum Park · 1 shared paper, 2022 · strength 0.15
  19. Jong Ho Moon · 1 shared paper, 2022 · strength 0.15
  20. Il Sang Shin · 1 shared paper, 2022 · strength 0.15
  21. Joon Koo Han · 1 shared paper, 2019 · strength 0.11
  22. Su Joa Ahn · 1 shared paper, 2019 · strength 0.11
  23. Bo Ram Kim · 1 shared paper, 2019 · strength 0.11
  24. Kyung Mi Jang · 1 shared paper, 2017 · strength 0.07
  25. H.J. Park · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.